Federico Cappuzzo
Professor Solange Peters
Professor Yi-Long Wu
The Latest Clinical Considerations for Non-Small Cell Lung Cancer: A Global Approach
The Latest Clinical Considerations for Non-Small Cell Lung Cancer: A Global A...
Peter Schmid, FRCP, MD, PhD
Javier Cortes, MD, PhD
Keeping Pace in Women’s Cancers: Updates in Triple-Negative Breast Cancer
Jeffrey S. Weber, MD, PhD
Kimberly’s Concerning Mole: Exploring First-Line Treatment Strategies for Patients with Advanced Metastatic Melanoma
Kimberly’s Concerning Mole: Exploring First-Line Treatment Strategies for Pat...
Paul P. Doghramji, MD, FAAFP
Corey S. Cutler, MD, MPH, FRCPC
Doris M. Ponce, MD
Breakthroughs and Innovations: Managing Complex Cases in Graft-versus-Host Disease
Breakthroughs and Innovations: Managing Complex Cases in Graft-versus-Host Di...
Marianne J. Davies, DNP, ACNP, AOCNP
Julie R. Brahmer, MD, MSc
Addressing Barriers in Managing IRAEs Associated with Immune Checkpoint Inhibitor Therapy
Addressing Barriers in Managing IRAEs Associated with Immune Checkpoint Inhib...
Scott Kopetz, MD, PhD
Prof Eric Van Cutsem, MD, PhD
Latest Clinical Advances in the Treatment of BRAF V600E-Mutated Metastatic Colorectal Cancer
Latest Clinical Advances in the Treatment of BRAF V600E-Mutated Metastatic Co...
Mark A. Socinski, MD
Alexander Drilon, MD
Keeping Pace: Advances in RET Fusion-Positive NSCLC
Helena Yu, MD
Keeping Pace: Advances in First-Line Therapy for EGFR-mutated NSCLC
Gilberto de Lima Lopes Junior, MD, MBA, FAMS
Kai He, MD, PhD
Jyoti D. Patel, MD, FASCO
Keeping Pace with Immunotherapy Advances in Non-Small Cell Lung Cancer: Global Lessons
Keeping Pace with Immunotherapy Advances in Non-Small Cell Lung Cancer: Globa...
William D. Tap, MD
John Healey, MD
Best Practices in the Treatment of Tenosynovial Giant Cell Tumor (TGCT)
William J. Gradishar MD, FASCO, FACP
Perspectives for Clinical Practice: The Latest Advances for HER2-positive Metastatic Breast Cancer
Perspectives for Clinical Practice: The Latest Advances for HER2-positive Met...
Warner K. Huh, MD
Deborah K. Armstrong, MD
Robert L. Coleman, MD, FACOG, FACS
Keeping Pace in Women's Cancer: The Role of PARP Inhibitors in Ovarian Cancer
Giuseppe Curigliano, MD, PhD
Real-World Evidence and Clinical Decision-Making for HR-positive/HER2-negative Metastatic Breast Cancer
Real-World Evidence and Clinical Decision-Making for HR-positive/HER2-negativ...
Applying Real-World Evidence to Improve Clinical Decision-Making for Patients with HR-positive/HER2-negative Metastatic Breast Cancer
Applying Real-World Evidence to Improve Clinical Decision-Making for Patients...
D. Ross Camidge, MD, PhD
Luis Paz-Ares, MD, PhD
Acquired Resistance to Targeted Therapy of NSCLC: A Global Perspective
Shira Johnson, MD
Robert Vonderheide, MD
CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer
Loading...
Stay current with the best on medical education
Learn More
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We’re glad to see you’re enjoying Global Oncology Academy…but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.
